Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biological and clinical aspects of hyperthermia in cancer therapy.

Literature DB >> 3289367

Biological and clinical aspects of hyperthermia in cancer therapy.

J R Oleson¹, S K Calderwood, C T Coughlin, M W Dewhirst, L E Gerweck, F A Gibbs, D S Kapp.

Abstract

Entities: Disease

Mesh：

Year: 1988 PMID： 3289367 DOI： 10.1097/00000421-198806000-00013

Source DB: PubMed Journal: Am J Clin Oncol ISSN： 0277-3732 Impact factor: 2.339

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. Magnetomotive molecular nanoprobes.

Authors: Renu John; Stephen A Boppart
Journal: Curr Med Chem Date: 2011 Impact factor: 4.530

2. Mitigation of eddy current heating during magnetic nanoparticle hyperthermia therapy.

Authors: Robert V Stigliano; Fridon Shubitidze; James D Petryk; Levan Shoshiashvili; Alicia A Petryk; P Jack Hoopes
Journal: Int J Hyperthermia Date: 2016-07-20 Impact factor: 3.914

3. Thermotolerance of mammalian cells is not induced near the restriction point of the G1 phase of the cell cycle.

Authors: A A Kudryavtsev; V P Lavrovskaya; O A Pivovarova; E I Lezhnev; L M Chailakhyan
Journal: Dokl Biol Sci Date: 2006 Nov-Dec

Review 4. Appendiceal Mucinous Neoplasms: Diagnosis and Management.

Authors: Walid L Shaib; Rita Assi; Ali Shamseddine; Olatunji B Alese; Charles Staley; Bahar Memis; Volkan Adsay; Tanios Bekaii-Saab; Bassel F El-Rayes
Journal: Oncologist Date: 2017-06-29

5. Magnetic nanoparticles with high specific absorption rate of electromagnetic energy at low field strength for hyperthermia therapy.

Authors: Fridon Shubitidze; Katsiaryna Kekalo; Robert Stigliano; Ian Baker
Journal: J Appl Phys Date: 2015-03-03 Impact factor: 2.546

10. Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma: the experience of the Tuscan Reference Centre.

Authors: Marcello Pace; Riccardo Gattai; Maria Matteini; Erminia Macera Mascitelli; Paolo Bechi
Journal: J Exp Clin Cancer Res Date: 2008-11-12

Biological and clinical aspects of hyperthermia in cancer therapy.

Review 1. Magnetomotive molecular nanoprobes.

2. Mitigation of eddy current heating during magnetic nanoparticle hyperthermia therapy.

3. Thermotolerance of mammalian cells is not induced near the restriction point of the G1 phase of the cell cycle.

Review 4. Appendiceal Mucinous Neoplasms: Diagnosis and Management.

5. Magnetic nanoparticles with high specific absorption rate of electromagnetic energy at low field strength for hyperthermia therapy.

6. Polyamine regulation of heat-shock-induced spermidine N1-acetyltransferase activity.

7. Nanoparticle based cancer treatment: can delivered dose and biological dose be reliably modeled and quantified?

8. MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT.

Review 9. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.

10. Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma: the experience of the Tuscan Reference Centre.